Diagnostics (Apr 2022)

Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis

  • Dimitrios A. Vrachatis,
  • Konstantinos A. Papathanasiou,
  • Dimitrios Kazantzis,
  • Jorge Sanz-Sánchez,
  • Sotiria G. Giotaki,
  • Konstantinos Raisakis,
  • Andreas Kaoukis,
  • Charalampos Kossyvakis,
  • Gerasimos Deftereos,
  • Bernhard Reimers,
  • Dimitrios Avramides,
  • Gerasimos Siasos,
  • Michael Cleman,
  • George Giannopoulos,
  • Alexandra Lansky,
  • Spyridon Deftereos

DOI
https://doi.org/10.3390/diagnostics12051026
Journal volume & issue
Vol. 12, no. 5
p. 1026

Abstract

Read online

Isolated coronary artery ectasia (CAE) is a relatively rare clinical entity, the pathogenesis of which is poorly understood. More and more evidence is accumulating to suggest a critical inflammatory component. We aimed to elucidate any association between neutrophil to lymphocyte ratio and coronary artery ectasia. A systematic MEDLINE database, ClinicalTrials.gov, medRxiv, Scopus and Cochrane Library search was conducted: 50 studies were deemed relevant, reporting on difference in NLR levels between CAE patients and controls (primary endpoint) and/or on high-sensitive CRP, IL-6, TNF-a and RDW levels (secondary endpoint), and were included in our final analysis. (PROSPERO registration number: CRD42021224195). All inflammatory biomarkers under investigation were found higher in coronary artery ectasia patients as compared to healthy controls (NLR; SMD = 0.73; 95% CI: 0.27–1.20, hs-CRP; SMD = 0.96; 95% CI: 0.64–1.28, IL-6; SMD = 2.68; 95% CI: 0.95–4.41, TNF-a; SMD = 0.50; 95% CI: 0.24–0.75, RDW; SMD = 0.56; 95% CI: 0.26–0.87). The main limitations inherent in this analysis are small case-control studies of moderate quality and high statistical heterogeneity. Our findings underscore that inflammatory dysregulation is implicated in coronary artery ectasia and merits further investigation.

Keywords